Josh Shachar

Josh Shachar is a co-founder of Cognos Therapeutics and serves as a Board Member and Chief Innovation Officer for the company. He has been involved in advanced technologies for the Department of Defense for over 20 years. Mr. Shachar has held many executive management positions at high-technology companies dealing directly with the United States Department of Defense. Mr. Shachar began his professional career in 1981 at ThermoControl, Inc. in Chatsworth, California, as the founder and Vice President of Engineering. This company was acquired by Daily Instrument of Houston, Texas. In 1996, Mr. Shachar served as the Vice President of Engineering at Pastushin Aviation, Inc. In the following year, Mr. Shachar founded and served as the President of Lambda Signatics, Inc., which was later acquired by Shapco Industries. Mr. Shachar is still the principal owner and founder of numerous high-technology companies including ThermoCouple America LLC, EDEL Engineering Development Corp., and Engineered Magnetics, Inc. Mr. Shachar is an author of numerous U.S. Patent applications in medical, biometrics, and diagnostic applications.

Mr. Shachar attended the prestigious Sorbonne University in Paris, France. After completing his studies there, Josh returned to Israel where he graduated magna cum laude with a Bachelors’s and Masters’s degree in Philosophy of Science and Mathematics. His high academic standards and passion earned him a Fullbright Scholarship which he used to begin a doctoral program at the University of Southern California.

Mr. Shachar holds more than 90 patents related to his advanced medical device technology and his work has been published in several leading journals.